A Cross-Field Fusion Strategy for Drug-Target Interaction Prediction
Hongzhi Zhang, Xiuwen Gong, Shirui Pan, Jia Wu, Bo Du, Wenbin Hu
TL;DR
This work tackles the challenge of predicting drug–target interactions for novel drugs and targets by integrating local and global protein information through a cross-field fusion strategy. The proposed SiamDTI uses a dual-channel, Siamese architecture with shared protein encoders and a bilinear attention-based fusion to derive a discriminative joint representation, achieving state-of-the-art performance on novel DTIs while remaining competitive for known DTIs. Key contributions include the PPI-enabled global protein channel, a BAN-based pairwise fusion module, and a complexity-aware design that reduces parameters via shared encoders. The approach promises improved robustness and scalability for large-scale virtual screening in drug discovery.
Abstract
Drug-target interaction (DTI) prediction is a critical component of the drug discovery process. In the drug development engineering field, predicting novel drug-target interactions is extremely crucial.However, although existing methods have achieved high accuracy levels in predicting known drugs and drug targets, they fail to utilize global protein information during DTI prediction. This leads to an inability to effectively predict interaction the interactions between novel drugs and their targets. As a result, the cross-field information fusion strategy is employed to acquire local and global protein information. Thus, we propose the siamese drug-target interaction SiamDTI prediction method, which utilizes a double channel network structure for cross-field supervised learning.Experimental results on three benchmark datasets demonstrate that SiamDTI achieves higher accuracy levels than other state-of-the-art (SOTA) methods on novel drugs and targets.Additionally, SiamDTI's performance with known drugs and targets is comparable to that of SOTA approachs. The code is available at https://anonymous.4open.science/r/DDDTI-434D.
